These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 25400539)

  • 21. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR Brain Screening using Optimization Techniques - A Survey.
    Chitradevi D; Prabha S
    Curr Med Imaging; 2023; 19(2):126-135. PubMed ID: 34825877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET.
    Matsuda H; Shigemoto Y; Sato N
    Jpn J Radiol; 2019 Nov; 37(11):735-749. PubMed ID: 31493197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET molecular imaging for pathophysiological visualization in Alzheimer's disease.
    Wang J; Jin C; Zhou J; Zhou R; Tian M; Lee HJ; Zhang H
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):765-783. PubMed ID: 36372804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
    Thal DR; Attems J; Ewers M
    J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention.
    Udeh-Momoh C; Zheng B; Sandebring-Matton A; Novak G; Kivipelto M; Jönsson L; Middleton L
    J Prev Alzheimers Dis; 2022; 9(1):12-21. PubMed ID: 35098969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET amyloid-beta imaging in preclinical Alzheimer's disease.
    Vlassenko AG; Benzinger TL; Morris JC
    Biochim Biophys Acta; 2012 Mar; 1822(3):370-9. PubMed ID: 22108203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers in Alzheimer's disease.
    Janeiro MH; Ardanaz CG; Sola-Sevilla N; Dong J; Cortés-Erice M; Solas M; Puerta E; Ramírez MJ
    Adv Lab Med; 2021 Mar; 2(1):27-50. PubMed ID: 37359199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised.
    Fjell AM; Walhovd KB
    Mol Neurobiol; 2012 Feb; 45(1):153-72. PubMed ID: 22201015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applied multimodal diagnostics in a case of presenile dementia.
    Schönecker S; Brendel M; Huber M; Vollmar C; Huppertz HJ; Teipel S; Okamura N; Levin J; Rominger A; Danek A
    BMC Neurol; 2016 Aug; 16():131. PubMed ID: 27506761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in pre-clinical diagnosis of Alzheimer's disease.
    Zhou J; Benoit M; Sharoar MG
    Metab Brain Dis; 2022 Aug; 37(6):1703-1725. PubMed ID: 33900524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging.
    de la Torre J
    J Alzheimers Dis; 2018; 63(1):35-52. PubMed ID: 29614675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and Imaging Biomarkers in Alzheimer's Disease: A Focus on Recent Insights.
    Villa C; Lavitrano M; Salvatore E; Combi R
    J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32664352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility and acceptance of simultaneous amyloid PET/MRI.
    Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study.
    Varma VR; Wang Y; An Y; Varma S; Bilgel M; Doshi J; Legido-Quigley C; Delgado JC; Oommen AM; Roberts JA; Wong DF; Davatzikos C; Resnick SM; Troncoso JC; Pletnikova O; O'Brien R; Hak E; Baak BN; Pfeiffer R; Baloni P; Mohmoudiandehkordi S; Nho K; Kaddurah-Daouk R; Bennett DA; Gadalla SM; Thambisetty M
    PLoS Med; 2021 May; 18(5):e1003615. PubMed ID: 34043628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG-PET and amyloid-PET imaging: the diverging paths.
    Perani D
    Curr Opin Neurol; 2014 Aug; 27(4):405-13. PubMed ID: 24927239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.
    Ossenkoppele R; van der Kant R; Hansson O
    Lancet Neurol; 2022 Aug; 21(8):726-734. PubMed ID: 35643092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
    Koychev I; Hofer M; Friedman N
    J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.